Clinical Trial

Prevalence of Obesity in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Study acronym: LeanMASLD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Our study will assess the prevalence of obesity among patients with (MASLD) and to evaluate the characteristics of lean MAFLD patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-28.
Trial Details
NCT Number NCT07451366
Lead Sponsor Assiut University
Conditions Lean MASLD
Enrollment 200 participants
Start Date 2026-07-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-06